Harlan JM - Search Results

1

Over-expression of Bcl-2 provides protection in septic mice by a trans effect.

Iwata A, Stevenson VM, Minard A, Tasch M, Tupper J, Lagasse E, Weissman I, Harlan JM, Winn RK. Iwata A, et al. Among authors: harlan jm. J Immunol. 2003 Sep 15;171(6):3136-41. doi: 10.4049/jimmunol.171.6.3136. J Immunol. 2003. PMID: 12960340

2

A broad-spectrum caspase inhibitor attenuates allergic airway inflammation in murine asthma model.

Iwata A, Nishio K, Winn RK, Chi EY, Henderson WR Jr, Harlan JM. Iwata A, et al. Among authors: harlan jm. J Immunol. 2003 Mar 15;170(6):3386-91. doi: 10.4049/jimmunol.170.6.3386. J Immunol. 2003. PMID: 12626599

3

Extracellular BCL2 proteins are danger-associated molecular patterns that reduce tissue damage in murine models of ischemia-reperfusion injury.

Iwata A, Morgan-Stevenson V, Schwartz B, Liu L, Tupper J, Zhu X, Harlan J, Winn R. Iwata A, et al. PLoS One. 2010 Feb 8;5(2):e9103. doi: 10.1371/journal.pone.0009103. PLoS One. 2010. PMID: 20161703 Free PMC article.

4

Requirement for RhoA kinase activation in leukocyte de-adhesion.

Liu L, Schwartz BR, Lin N, Winn RK, Harlan JM. Liu L, et al. Among authors: harlan jm. J Immunol. 2002 Sep 1;169(5):2330-6. doi: 10.4049/jimmunol.169.5.2330. J Immunol. 2002. PMID: 12193698

5

The caspase inhibitor z-VAD is more effective than CD18 adhesion blockade in reducing muscle ischemia-reperfusion injury: implication for clinical trials.

Iwata A, Harlan JM, Vedder NB, Winn RK. Iwata A, et al. Among authors: harlan jm. Blood. 2002 Sep 15;100(6):2077-80. doi: 10.1182/blood-2002-03-0752. Blood. 2002. PMID: 12200369 Free article.

6

Shiga toxin induces decreased expression of the anti-apoptotic protein Mcl-1 concomitant with the onset of endothelial apoptosis.

Erwert RD, Eiting KT, Tupper JC, Winn RK, Harlan JM, Bannerman DD. Erwert RD, et al. Among authors: harlan jm. Microb Pathog. 2003 Aug;35(2):87-93. doi: 10.1016/s0882-4010(03)00100-1. Microb Pathog. 2003. PMID: 12901848

7

Extracellular administration of BCL2 protein reduces apoptosis and improves survival in a murine model of sepsis.

Iwata A, de Claro RA, Morgan-Stevenson VL, Tupper JC, Schwartz BR, Liu L, Zhu X, Jordan KC, Winn RK, Harlan JM. Iwata A, et al. Among authors: harlan jm. PLoS One. 2011 Feb 24;6(2):e14729. doi: 10.1371/journal.pone.0014729. PLoS One. 2011. PMID: 21390214 Free PMC article.

8

P-selectin blockade does not impair leukocyte host defense against bacterial peritonitis and soft tissue infection in rabbits.

Sharar SR, Sasaki SS, Flaherty LC, Paulson JC, Harlan JM, Winn RK. Sharar SR, et al. Among authors: harlan jm. J Immunol. 1993 Nov 1;151(9):4982-8. J Immunol. 1993. PMID: 7691961

9

Ischemia reperfusion injury in the rabbit ear is reduced by both immediate and delayed CD18 leukocyte adherence blockade.

Sharar SR, Mihelcic DD, Han KT, Harlan JM, Winn RK. Sharar SR, et al. Among authors: harlan jm. J Immunol. 1994 Sep 1;153(5):2234-8. J Immunol. 1994. PMID: 7914218

10

L-selectin (CD62L) blockade does not impair peritoneal neutrophil emigration or subcutaneous host defense to bacteria in rabbits.

Sharar SR, Chapman NN, Flaherty LC, Harlan JM, Tedder TF, Winn RK. Sharar SR, et al. Among authors: harlan jm. J Immunol. 1996 Sep 15;157(6):2555-63. J Immunol. 1996. PMID: 8805657

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

225 results

Search Page

Filters